Global Board Directors

Richard T. Clark

Richard T. Clark

Chairman of the board May 1, 2010 to November 30, 2011. Former CEO and president, Merck. Chairman of the board, Project Hope. Advisory board member, American Securities. Director, Automatic Data Processing (ADP), Inc. Trustee, Washington Jefferson College and PENN Medicine. PhRMA board chairman (2008-09). Merck director since November 3, 2009.

Leslie A. Brun

Leslie A. Brun

Chairman and chief executive officer, Sarr Group, LLC (investment holding company). Non-executive chairman, Automatic Data Processing, Inc. Director, Philadelphia Media Holdings, LLC, and Broadridge Financial Solutions, Inc. Merck director since November 3, 2009

Thomas R. Cech

Thomas R. Cech, Ph.D.

Investigator, Howard Hughes Medical Institute.
Faculty, University of Colorado. Merck director since November 3, 2009

Kenneth C. Frazier

Kenneth C. Frazier

President and chief executive officer, Merck & Co., Inc. Director Exxon Mobil, The Pennsylvania State University, Cornerstone Christian Academy. Merck director since January 1, 2011.

Thomas H. Glocer

Thomas H. Glocer

Chief executive officer, Thomson Reuters Corporation (information and services company for businesses and professionals). Director, Thomson Reuters Corporation, Partnership for New York City. Merck director since November 3, 2009

Steven F. Goldstone

Steven F. Goldstone

Retired chairman and chief executive officer, RJR Nabisco, Inc. Managing partner, Silver Spring Group (private investment firm). Non-executive chairman, ConAgra Foods, Inc. Director, Greenhill & Co., Inc. Merck director since November 3, 2009

William B. Harrison, Jr.

William B. Harrison, Jr.

Lead director of the Board. Retired chairman of the board, JPMorgan Chase & Co. (financial services). Director, Aurora Capital Group, Cousins Properties Incorporated, Lincoln Center for Performing Arts and RecoverCare LLC. Merck director since November 3, 2009

Harry R. Jacobson, M.D.

Harry R. Jacobson, M.D.

Vice chancellor, Health Affairs, Emeritus (since June 2009), Vanderbilt University. Non-executive chairman, CeloNova BioSciences, Inc. Director, BioNumerik Pharmaceuticals Inc., Ingram Industries, Inc. and Kinetic Concepts, Inc. Merck director since November 3, 2009

William N. Kelley, M.D.

William N. Kelley, M.D.

Professor of Medicine, Biochemistry and Biophysics, University of Pennsylvania School of Medicine. Director, Beckman Coulter, Inc. and GenVec, Inc. Merck director since November 3, 2009

C. Robert Kidder

C. Robert Kidder

Chairman and chief executive officer, 3Stone Advisors LLC (private investment firm). Chairman of the board of directors, Chrysler Group LLC. Director, Morgan Stanley and Microvi Biotech Inc. Merck director since December 5, 2005

Rochelle B. Lazarus

Rochelle B. Lazarus

Chairman, Ogilvy & Mather Worldwide (advertising and marketing communication company). Director, General Electric. Trustee, New York Presbyterian Hospital and American Museum of Natural History. Merck director since November 3, 2009

Carlos E. Represas

Carlos E. Represas

Former chairman, Nestle Group Mexico. Director, Bombardier Inc. Merck director since November 3, 2009

Patricia F. Russo

Patricia F. Russo

Former chief executive officer and director, Alcatel-Lucent. Director, Alcoa, Inc., General Motors Company and Hewlett-Packard. Merck director since September 1, 1995

Thomas E. Shenk

Thomas E. Shenk, Ph.D.

Elkins Professor, Department of Molecular Biology, Princeton University. Director, Fox Chase Cancer Center and Origen Therapeutics, Inc. Merck director since November 3, 2009

Anne M. Tatlock

Anne M. Tatlock

Retired chairman of the board and chief executive officer, Fiduciary Trust Company International (global asset management services). Director, Fortune Brands, Inc., and Franklin Resources, Inc. Merck director since November 3, 2009

Craig B. Thompson, M.D.

Craig B. Thompson, M.D.

President and CEO, Memorial Sloan-Kettering Cancer Center. Director, American Association for Cancer Research. Merck director since January 2, 2008

Wendell P. Weeks

Wendell P. Weeks

Chairman and chief executive officer, Corning Incorporated (technology company in telecommunications, information display and advanced materials industries). Director, Corning Incorporated. Merck director since November 3, 2009

Peter C. Wendell

Peter C. Wendell

Managing director, Sierra Ventures (technology-oriented venture capital firm). Faculty, Stanford University Graduate School of Business. Merck director since November 3, 2009

Derechos reservados ©2012 Merck Sharp & Dohme Corp. Una subsidiaria de Merck & Co., Inc., Kenilworth, NJ, USA. Todos los derechos reservados.

TRUSTe - Click to Verify